Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6568
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
ASBIMA HCT 10MG/320MG/25MG TBL FLM 98 II
0245404 58/ 360/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/320MG/25MG TBL FLM 28 III
0245405 58/ 360/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/320MG/25MG TBL FLM 30 III
0245406 58/ 360/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/320MG/25MG TBL FLM 90 III
0245407 58/ 360/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 10MG/320MG/25MG TBL FLM 98 III
0245408 58/ 360/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 14 I
0245343 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 28 I
0245344 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 30 I
0245345 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 90 I
0245346 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 98 I
0245347 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 14 II
0245348 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 28 II
0245349 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 30 II
0245350 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 90 II
0245351 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 98 II
0245352 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 14 III
0245353 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 28 III
0245354 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 30 III
0245355 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 90 III
0245356 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R
ASBIMA HCT 5MG/160MG/12,5MG TBL FLM 98 III
0245357 58/ 356/19-C asbimahct.pdf asbimahct.pdf C09DX01 R

‹‹ ‹ 10 20 30 37 38 39 40 41 42 43 44 45 46 47 50 60 70 80 90 200 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 2. March 2021 at 00:08
Last update of price and payment data: 27. February 2021 at 00:09